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Abstract
Celiac disease (CD), or gluten-sensitive enteropathy, is one of the most common chronic 
diseases in childhood but is diagnosed in all ages. CD is a genetically driven immu-
nological intolerance to dietary gluten. Th e treatment is a gluten-free diet. Th e diagnos-
tic criteria are the ESPGHAN criteria, which include the histological characteristics of 
villous atrophy, crypt hyperplasia and increased number of intraepithelial lymphocytes 
(IEL). Th e clinical manifestations in CD range from severely aﬀ ected young children to 
children and adults with milder symptoms as well as patients with silent CD. Th ere is a 
strong heredity in CD with the well-known HLA components DQ2 and DQ8. Th e ge-
netics in CD are believed to confer up to 40% HLA genetics and otherwise non-HLA 
genetics. Th e knowledge of the genotype-phenotype association in CD is limited.
Th e aim of this study has been to estimate the risk of a third sibling be-
ing aﬀ ected in CD sib-pair families, identify the chromosomal region contain-
ing susceptibility genes in CD and study the genotype-phenotype association in CD.
Material was collected from 107 families with at least two aﬀ ected siblings, making a total 
of 224 CD siblings, as well as their healthy siblings and parents. Screening for CD was 
performed in these apparently healthy members and the estimated risk for CD in the third 
sibling and parent was then calculated. Th irteen new CD cases were diagnosed, six siblings 
and seven parents. Th e estimated sibling risk was 26.3% and the parent risk was 12.9%. 
Th e risk of a sibling of two aﬀ ected siblings having CD was approximately three times high-
er compared to siblings of one aﬀ ected sibling. Considering the high level of knowledge 
of CD in these families, the number of undiagnosed cases was surprisingly high. We sug-
gested that serological screening should be oﬀ ered all ﬁ rst-degree relatives of CD patients.
Genome-wide linkage scan was performed in the same material. Th is work showed signiﬁ cant 
evidence of linkage to CD with an interesting region on chromosome 5q31-33 and on chro-
mosome 11q. Simplex CD family material was collected for further genetic association studies.
Th e phenotype-genotype association was examined in two studies. An investigation was made of 
a possible interaction between the phenotypes and HLA class II risk alleles, the CTLA4 +49 A/G 
polymorphism, the haplotype MH30*G:-1147*T:+49*A:CT60*G:CT61*A and the 5q31-33 
locus, in CD. Th e patients were grouped according to symptoms at presentation, the age at diag-
nosis and gender. Th e heritability of the phenotype was estimated to be 0.45. Th e AA genotype 
at the CTLA4 +49A/G polymorphism was associated with clinically silent disease. No other 
correlations were found between genotypes and clinical presentation, age at diagnosis or gender.
A genotype-phenotype analysis was made of phenotypes in DQ2-negative CD patients in 
the largest DQ2-negative CD group that has been published compared to DQ2-positive CD 
controls in a European population. Th e ﬁ nding was that the clinical presentation diﬀ ered 
signiﬁ cantly between DQ2-negative and DQ2-positive CD patients in Italy and Sweden. In 
both samples there was an association between DQ2-negative cases and classic symptoms. 
In the Italian sample there was also an association between silent grade and DQ2-nega-
tive cases. Autoimmune disease was signiﬁ cantly overrepresented in DQ8-positive patients. 
Th is thesis shows that the risk for third sibling and parents is, as expected, increased in 
sib-pair families, as the expected risk of being aﬀ ected in polygenic diseases is higher in 
families with multiple cases compared to single-case families. Th e genome scan indi-
cated signiﬁ cant linkage to 11q and 5q, which makes these regions interesting for fur-
ther ﬁ ne mapping of these regions using association analysis. Genotype-phenotype 
analysis of both HLA and non-HLA locus showed some signiﬁ cant correlation be-
tween silent CD and both CTLA4 +49 AA genotype and the DQ2-negatives. In addi-
tion, an association was shown between classic symptom grade and DQ2-negative cases.
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